Results 81 to 90 of about 27,780 (214)

Carbapenemase-producing carbapenem-resistant Enterobacteriaceae, Chlamydia trachomatis infection, Chancroid: (Week 49) Weekly cases* of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents week ending December 11, 2021 [PDF]

open access: yes
This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Carbapenemase-producing carbapenem-resistant Enterobacteriaceae; Chlamydia trachomatis infection; Chancroid cases ...

core   +2 more sources

Metabolism‐Based Biomarkers for Rapid Phenotypic Antibiotic Susceptibility Testing

open access: yesAdvanced Science, Volume 13, Issue 33, 15 June 2026.
Metabolic differences emerging after antibiotic exposure provide rapid phenotypic signals of susceptibility and resistance. This review summarizes metabolic biomarkers for rapid phenotypic AST, associated with nutrient uptake, respiratory activity, metabolic reprogramming, and enzymatic function. ABSTRACT The accelerating global crisis of antimicrobial
Sha Yu   +7 more
wiley   +1 more source

Use of meropenem in treating carbapenem-resistant Enterobacteriaceae infections [PDF]

open access: yes, 2019
Introduction: The epidemiology of carbapenem-resistant Enterobacterales (CRE) is increasingly worldwide. Production of carbapenemases is the most common and efficient mechanism of carbapenem resistance, and could theoretically be overcome by optimizing ...
Pea F.   +4 more
core   +3 more sources

A systematic review and meta-analysis of carbapenem resistance and its possible treatment options with focus on clinical Enterobacteriaceae: Thirty years of development in Pakistan

open access: yesHeliyon
Background: Carbapenem resistance is epidemic worldwide, these last resort antimicrobials are listed in the WHO ‘watch group’ with higher resistance potential.
Muhammad Umair   +2 more
doaj   +1 more source

In-vitro activity of eravacycline against carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii [PDF]

open access: yes, 2016
Eravacycline and comparators were tested against carbapenem- and tigecycline-resistant Enterobacteriaceae and Acinetobacter received at the United Kingdom's national reference laboratory Eravacycline MICs correlated closely with those of tigecycline but ...
Warner, Marina   +3 more
core   +1 more source

Carbapenem-resistant Enterobacteriaceae (CRE) [PDF]

open access: yes
Type: BacteriaAlso known as: Nightmare bacteriaAbout: CRE are a major concern for patients in healthcare facilities. Some Enterobacteriaceae (a family of germs) are resistant to nearly all antibiotics, leaving more toxic or less effective treatment ...

core  

Antibiotic Resistance Profile of Wound Infection Isolates: High Resistance to Cephalosporins and Penicillin Among Ghanaian Patients in a Cross‐Sectional Study

open access: yesHealth Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aim Antibiotics remain among the most frequently prescribed medications in clinical practice. However, antimicrobial resistance (AMR) is an inevitable and irreversible consequence of bacterial adaptation to antimicrobial exposure.
Nelson Kwashie   +6 more
wiley   +1 more source

Characteristics Associated to Carbapenem-Resistant Enterobacteriaceae Fecal Carriage. [PDF]

open access: yes, 2015
CRE, carbapenem-resistant Enterobacteriaceae; IQR, interquartile range; MDRO, multi-drug resistant organism.Data about hospitalization exposures occurred before the last screening culture.a Systemic lupus erythematosus, rheumatoid arthritis, Sjögren ...
Luis Pablo Cruz-Hervert (406949)   +10 more
core   +1 more source

Identification of Carbapenemase Enzymes in Clinical Isolates of Enterobacteriaceae Using Modified Hodge Test

open access: yesمجله دانشکده پزشکی اصفهان, 2014
Background: Carbapenem antibiotics are a subtype of beta-lactam antibiotics, which can play an important role in the treatment of severe infections and multi-drug resistant bacteria.
Reza Kamali Kakhki   +3 more
doaj  

Home - About - Disclaimer - Privacy